Bionano Genomics (STU:2Y30) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2Y30 Bionano Genomics Inc STU:2Y30
64 GF Score
Price €315.84
GF Value €422.95
! 3 Warning Signs
View Full Analysis

What is Bionano Genomics FFO?

FFO (Funds from operations) only applies to REITs.

STU:2Y30
64GF Score
Bionano Genomics Inc STU:2Y30
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bionano Genomics (STU:2Y30) Overvalued in 2026?

Based on GuruFocus' analysis, Bionano Genomics stock appears to be undervalued. The current stock price of €315.84 is trading 25.3% below its estimated GF Value™ of €422.95.

Key valuation signals for STU:2Y30:

  • FFO:
  • GF Value™: €422.95 vs. price of €315.84 (25.3% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the STU:2Y30 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bionano Genomics Business Description

Other Exchanges BNGO:USABNGO:Mexico
Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
64GF Score

Get the complete analysis for STU:2Y30

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€315.84
Price
€422.95
GF Value